Literature DB >> 18626433

Impact of diabetes mellitus on outcome of HCC.

Deepak N Amarapurkar1, Nikhil D Patel, Praful M Kamani.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is recently identified risk factor for development and progression of chronic liver disease as well as hepatocellular carcinoma (HCC). We planned a prospective analysis to identify impact of DM in Indian patients with HCC.
METHODS: During last 10 years, 160 consecutive patients of HCC were evaluated. Demographic profile like age of presentation, clinical features, etiology of HCC, tumor size at presentation, management and ultimate outcome was compared diabetic with non-diabetic HCC patients.
RESULTS: During last 10 years, 160 consecutive patients of HCC were evaluated (Mean age = 59.6 +/- 12.9 years, sex ratio (M: F) = 5.4: 1). Etiology for HCC were hepatitis B in 45 (28.2%), hepatitis C in 18 (11.3%), alcohol in 27 (16.8%), alcohol with hepatitis B in 12 (7.5%), alcohol with hepatitis C in 1 (0.6%), non-alcoholic steatohepatitis in 4 (2.5%) and cryptogenic in 53 (33.2%) patients. Patients of HCC with DM (group-A, n =46, age = 62.6 +/- 9.5 years, sex (M: F) = 6.6:1) were compared with patient of HCC without DM (group-B, n =114, age = 66.7 +/- 13.7 years, sex (M: F) = 5.4:1). Duration of diabetes in group-A was 7.6 +/- 3.2 years. Patients in group-A had more advanced HCC (size of lesion > 5 cm and >3 lesions of 3 cm or more diameter, portal vein thrombosis or intra-hepatic bile duct involvement) than group-B [34 (73.9%) vs 72 (54.3%)]. Mortality with in one year was significantly more in group-A compared to group-B [36 (78.2%) vs 56 (49.1%)].
CONCLUSION: DM is associated with more advanced lesion and poor outcome in patient with HCC.

Entities:  

Mesh:

Year:  2008        PMID: 18626433

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  17 in total

1.  Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.

Authors:  Ankita Makol; Shruthi Kanthaje; Radha K Dhiman; Naveen Kalra; Yogesh K Chawla; Anuradha Chakraborti
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-29

2.  Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Authors:  Valter Donadon; Massimiliano Balbi; Francesca Valent; Angelo Avogaro
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

Review 3.  The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Vivek A Saraswat; Anil Arora; Ajay Duseja; Mahesh K Goenka; Deepali Jain; Premashish Kar; Manoj Kumar; Vinay Kumaran; Kunisshery M Mohandas; Dipanjan Panda; Shashi B Paul; Jeyamani Ramachandran; Hariharan Ramesh; Padaki N Rao; Samir R Shah; Hanish Sharma; Ragesh B Thandassery
Journal:  J Clin Exp Hepatol       Date:  2014-05-22

4.  Association of nonalcoholic fatty liver disease and liver cancer.

Authors:  Perla Oliveira Schulz; Fabio Gonçalves Ferreira; Maria de Fátima Araújo Nascimento; Andrea Vieira; Mauricio Alves Ribeiro; André Ibrahim David; Luiz Arnaldo Szutan
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 5.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 6.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population.

Authors:  Tao Jiang; Longjiu Cui; Libo Chen; Zhongxiang Liu; Hui Ren
Journal:  Med Oncol       Date:  2014-02-26       Impact factor: 3.064

8.  Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Authors:  Jyh-Der Leu; I-Feng Lin; Ying-Fang Sun; Su-Mei Chen; Chih-Chao Liu; Yi-Jang Lee
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

9.  Is diabetes mellitus a poor prognostic factor for hepatocellular carcinoma?

Authors:  Muhammed Adnan Masood; Waleed Zafar; Muhammed Aasim Yusuf
Journal:  J Gastrointest Cancer       Date:  2014-12

10.  Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.

Authors:  Yuan Chen; Xiulong Song; Leila Valanejad; Alexander Vasilenko; Vijay More; Xi Qiu; Weikang Chen; Yurong Lai; Angela Slitt; Matthew Stoner; Bingfang Yan; Ruitang Deng
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.